Altogether, data demonstrate that UGT2B17 interacts with several kinases of the BCR signaling pathway in a constitutive manner and imply that the UGT2B17 protein could promote CLL progression independently of its transferase activity through functional association with BCR-related proteins. Here, UGT2B17 is linked to B-cell chronic lymphocytic leukemia.